Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-09

Clinical Trial Update: Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating sphenopalatine ganglion block for anxiety at electronic dance music festivals; recruitment has not started yet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sphenopalatine ganglion block

Snippet

Sponsor: University of Calgary | Conditions: Anxiety | Phase 2 | Status: NOT_YET_RECRUITING